Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 4:26 pm Purchase | 13G | Assertio Therapeutics Inc ASRT | D. E. SHAW & CO L.P. | 4,506,585 5.6% | 447,169 (+11.02%) | View |
| 2020-02-14 4:26 pm Sale | 13G | Mallinckrodt plc MNKTQ | D. E. SHAW & CO L.P. | 253,232 0.3% | -4,274,802 (-94.41%) | View |
| 2020-02-14 4:26 pm Sale | 13G | NEVRO CORP NVRO | D. E. SHAW & CO L.P. | 1,932,518 6.2% | -183,706 (-8.68%) | View |
| 2020-01-21 4:02 pm Purchase | 13G | APPLIED OPTOELECTRONICS INC. AAOI | D. E. SHAW & CO L.P. | 1,172,528 5.7% | 82,128 (+7.53%) | View |
| 2020-01-10 4:03 pm Purchase | 13G | PYXUS INTERNATIONAL INC. PYYX | D. E. SHAW & CO L.P. | 460,289 5% | 244 (+0.05%) | View |
| 2020-01-06 4:06 pm Purchase | 13G | APPLIED OPTOELECTRONICS INC. AAOI | D. E. SHAW & CO L.P. | 1,090,400 5.3% | 1,082,797 (+14241.71%) | View |
| 2019-12-23 4:01 pm Purchase | 13G | PYXUS INTERNATIONAL INC. PYYX | D. E. SHAW & CO L.P. | 460,045 5% | 460,045 (New Position) | View |
| 2019-11-21 4:01 pm Purchase | 13G | HIBBETT INC HIBB | D. E. SHAW & CO L.P. | 1,325,562 7.5% | 423,700 (+46.98%) | View |
| 2019-11-18 4:06 pm Purchase | 13G | NEVRO CORP NVRO | D. E. SHAW & CO L.P. | 2,116,224 6.8% | 306,150 (+16.91%) | View |
| 2019-11-18 4:05 pm Purchase | 13G | STAMPS.COM INC STMP | D. E. SHAW & CO L.P. | 1,419,828 8.3% | 8,107 (+0.57%) | View |
| 2019-11-15 4:01 pm Purchase | 13G | CLOVIS ONCOLOGY INC CLVSQ | D. E. SHAW & CO L.P. | 2,955,517 5.4% | 131,196 (+4.65%) | View |
| 2019-11-12 4:02 pm Purchase | 13G | Assertio Therapeutics Inc ASRT | D. E. SHAW & CO L.P. | 4,059,416 5% | 4,059,416 (New Position) | View |
| 2019-10-15 4:09 pm Purchase | 13G | STAMPS.COM INC STMP | D. E. SHAW & CO L.P. | 1,411,721 8.2% | 524,007 (+59.03%) | View |
| 2019-09-16 4:01 pm Sale | 13G | HIBBETT INC HIBB | D. E. SHAW & CO L.P. | 901,862 5% | -19,732 (-2.14%) | View |
| 2019-09-09 4:02 pm Purchase | 13G | ARCADIA BIOSCIENCES INC PA RKDA | D. E. SHAW & CO L.P. | 342,111 5.5% | 342,111 (New Position) | View |
| 2019-09-06 4:10 pm Purchase | 13G | BOWFLEX INC.INC. BFXXQ | D. E. SHAW & CO L.P. | 1,489,993 5% | 1,489,993 (New Position) | View |
| 2019-08-19 4:06 pm Purchase | 13G | CLOVIS ONCOLOGY INC CLVSQ | D. E. SHAW & CO L.P. | 2,824,321 5% | 2,824,321 (New Position) | View |
| 2019-08-19 4:06 pm Purchase | 13G | YELP INC YELP | D. E. SHAW & CO L.P. | 3,813,458 5.4% | 2,356,157 (+161.68%) | View |
| 2019-08-09 4:01 pm Purchase | 13G | LANNETT CO INC LCI | D. E. SHAW & CO L.P. | 3,375,318 8.6% | 711,916 (+26.73%) | View |
| 2019-07-05 4:01 pm Purchase | 13G | STAMPS.COM INC STMP | D. E. SHAW & CO L.P. | 887,714 5.1% | 887,714 (New Position) | View |